Cancer can be a devastating diagnosis for a patient, with the disease and traditional treatments having a significant impact on their quality of life. Global diagnoses are on the rise; with 27.5 million new cases of cancer expected each year by 20401.
Across the world, innovators are working to introduce CGTs to fight cancers and other chronic, life-threatening conditions. Also known to the life science industry and regulators as advanced therapy medicinal products (ATMPs), these cutting-edge treatments are proving to enhance the quality and efficacy of cancer patient care and hopefully, even provide a cure for their condition.
In this case study, discover how Nagaraj*, a young man living near Bengaluru, India and fighting a rare cancer was able to receive a ground-breaking autologous T-cell-based immunotherapy developed in Malaysia thanks to the logistics expertise of World Courier.